Drawing for ONETOUCH

USPTO serial 97213031

ONETOUCH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KIDWELL WALKER, JACLYN NOEMI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONETOUCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Katherine A. Markert

Katherine A. Markert MARKERT & COMINOLLI PLLC75 S. CLINTON AVE., SUITE 510ROCHESTER, NY 14604United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical control solutions for use with blood glucose monitoring devices; blood glucose control solutions; chemical solutions used for medical diagnostic purposesACTIVE—
005Reagent test strips used in testing for glucose in blood for medical diagnostic purposes; test strips for measuring blood glucose levels; test strips for use with blood glucose monitoring devicesACTIVE—
009Downloadable computer software for monitoring glucose levels and transmitting medical data; Downloadable computer software application for mobile devices, namely, software for diabetes management and glucose tracking; downloadable computer software, namely, software for diabetes management and glucose tracking; Downloadable computer software, namely, software embedded within a glucose meter or a device which offers the user diabetes management suggestions and guidance based on current and previous glucose results and other tracked data; Downloadable mobile application to facilitate support and sharing of health information to patients living with diabetes and diabetes-related conditions; downloadable mobile application to facilitate monitoring of health and wellness data to patients living with diabetes and diabetes-related conditions; downloadable mobile application to facilitate interaction between users and coaches via video, text and direct interaction to patients living with diabetes and diabetes-related conditionsACTIVE—
010Blood glucose meters and monitoring devices; embedded computer software, namely, software embedded within a blood glucose meter which offers the user diabetes management suggestions and guidance on current and previous glucose results and other tracked data sold as an integral component of a blood glucose meter; carrying case specifically adapted for carrying diabetic supplies, namely, blood glucose meter, testing strips and lancets; finger pricking devices used to draw blood for medical use; lancets; lancing devices used to draw blood to be used with blood glucose monitoring devices or for other medical uses; insulin pumpsACTIVE—
041Providing professional coaching services in the field of health management for patients living with diabetes and diabetes-related conditions; providing professional group coaching services to patients living with diabetes and diabetes-related conditions; educational services, namely, providing information in the nature of online tutorial videos and articles to patients about managing diabetes; providing information via a website relating to fitnessACTIVE—
044Providing an internet website portal featuring information in the field of health and wellness management; providing information in the field of health and wellness via the Internet; providing an interactive website featuring information and links relating to healthy living; providing information via a website relating to diabetes, weight loss, wellness, and support of chronic health conditions; providing an internet website portal in the field of diabetes monitoring devices and third-party wellness programs; providing information relating to health and wellness, namely, usage of blood glucose monitoring devices, insulin delivery devices and diabetesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 8, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 8, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 8, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 6, 2023EX1GSOU EXTENSION 1 GRANTED—
Sep 6, 2023EXT1SOU EXTENSION 1 FILED—
Sep 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 7, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 10, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 10, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 21, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 8, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 8, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Dec 8, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 8, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 8, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 7, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 8, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 24, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Oct 24, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 24, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 24, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 18, 2022DOCKASSIGNED TO EXAMINER—
Jan 18, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance